Literature DB >> 33846649

Identifying potential prescription drug product hopping.

Vrushab Gowda1,2, Reed F Beall1,3, Aaron S Kesselheim1, Ameet Sarpatwari4.   

Abstract

Year:  2021        PMID: 33846649     DOI: 10.1038/s41587-021-00877-9

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011.

Authors:  Walid F Gellad; Phillip Choi; Margaret Mizah; Chester B Good; Aaron S Kesselheim
Journal:  Am J Manag Care       Date:  2014-03-01       Impact factor: 2.229

2.  New Drug Formulations and Their Respective Generic Entry Dates.

Authors:  Reed F Beall; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  J Manag Care Spec Pharm       Date:  2019-02

3.  Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.

Authors:  Vincent C Capati; Aaron S Kesselheim
Journal:  J Manag Care Spec Pharm       Date:  2016-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.